SCHEMBL16213672

SCHEMBL16213672

COC(CCCNS(=O)(=O)c1ccc(CO)cc1)OC

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 11/20 0.50
▸ PKM P14618 3/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ MAPK1 P28482 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ LMNA P02545 2/20 0.43
▸ MAPT P10636 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ USP2 O75604 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19392455 0.77 MEN1 (0.61) ALDH1A1PKMSMN1; SMN2MEN1KMT2A
SCHEMBL9271788 0.77 ALDH1A1 (0.56) ALDH1A1PKMSMN1; SMN2MEN1KMT2A
SCHEMBL16213694 0.73 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2MAPK1NPC1HPGD
SCHEMBL28859611 0.72 ALDH1A1 (0.63) ALDH1A1MEN1KMT2ANPC1LMNA
SCHEMBL20730795 0.70 ALDH1A1 (0.77) ALDH1A1PKMSMN1; SMN2MEN1KMT2A
SCHEMBL8079254 0.69 ALDH1A1 (0.58) ALDH1A1PKMSMN1; SMN2MAPK1KDM4E
SCHEMBL5599840 0.68 MEN1 (0.66) ALDH1A1MEN1KMT2AHPGDLMNA
SCHEMBL1859957 0.68 CA1 (0.62) ALDH1A1SMN1; SMN2KDM4ENPC1HPGD
SCHEMBL31553561 0.68 MMP12 (0.39) ALDH1A1SMN1; SMN2HTT
SCHEMBL31553562 0.68 MMP12 (0.39) ALDH1A1SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2718280-B1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMA SPA (IT) 2015-09-16 — — EP disclosed
US-8877774-B2 Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activity CHIESI FARMACEUTICI S.P.A. (IT) 2014-11-04 — — US disclosed
US-8877774-B2 Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activity CHIESI FARMACEUTICI S.P.A. (IT) 2014-11-04 — — US disclosed
Send feedback